PET Scanners Market Research Report, Size , Growth, Trends, Opportunity Analysis, Industry Forecast - 2023-2027

Published: Oct 2023 Pages: 152 SKU: IRTNTR75552

PET Scanners Market Report 2023-2027

The pet scanners market size is estimated to grow by USD 477.85 million at a Compound Annual Growth Rate (CAGR) of 4.73% between 2023 and 2027. The market is driven by rising chronic disease cases demanding advanced diagnostic tools. Integration of AI into medical imaging enhances diagnostic accuracy and efficiency, driving market growth. Moreover, vendors' substantial investments in R&D to develop innovative PET scanning technologies contribute to market expansion. These factors collectively bolster the demand for PET scanners, addressing the diagnostic needs of various medical conditions efficiently.

What will be the size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

 

Market Segmentation

This market report extensively covers market segmentation by end-user (hospitals, diagnostic centers, and others), application (oncology, neurology, cardiology, and others), and (Europe, North America, APAC, and Rest of World (ROW)).

By End-User

The market share growth by the Hospitals segment will be significant during the forecast period. The demand for PET scanners is high among hospitals. PET scanners are highly effective in diagnosing and staging various medical conditions, including cancer, heart diseases, and neurological disorders. They provide doctors with an overview of metabolic and functional processes within the body, which allows them to identify abnormalities before they occur.

Get a glance at the market contribution of various segments View the PDF Sample

The hospitals segment shows a gradual increase in the market share of USD 746.74 million in 2017 and continue to grow by 2021PET imaging is vital for clinical research, particularly in the fields of oncology, neurology, and cardiology. It enables researchers to study disease progression, evaluate the effectiveness of new drugs or therapies, and monitor treatment outcomes. 

Key Regions

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in Europe is expected to witness moderate growth during the forecast period. It is driven by factors such as the increasing prevalence and incidence of cancer, the growing geriatric population, the high adoption of technologically advanced diagnostic devices, the ease in the process of regulatory approval, the surge in the number of PET scanners procedures, and the favorable reimbursement policies in the region. European countries with well-developed healthcare systems and a focus on advanced medical imaging are likely to have a higher demand. 

Market Dynamics and Customer Landscape

The market is witnessing significant growth, driven by its pivotal role in diagnosing complex conditions like dementia and epilepsy. Leveraging radioactive tracers and advanced PET detector technology, PET/CT imaging offers precise insights into oncology imaging and cardiovascular diseases. Key players like Novartis and GE Healthcare are pioneering innovations such as PluvictoTM, enhancing diagnostic accuracy. Despite high capital and operational costs, hospitals and medical centers continue to invest, supported by favorable reimbursement policies. As demand surges in diagnostic imaging centers, PET scanners remain indispensable in healthcare settings, ensuring early detection and comprehensive management of a wide array of medical conditions.

The increasing prevalence of chronic diseases is notably driving the market growth, although factors such as growing demand for High cost of market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The increasing prevalence of chronic diseases is notably driving the market growth. The increasing number of chronic diseases has contributed to an increase in demand for PET scanners. PET scanners are advanced medical imaging devices used to visualize and measure metabolic processes in the body. Chronic diseases such as cancer, cardiovascular disorders, neurological conditions, and metabolic disorders often require accurate diagnosis and monitoring. PET scans provide detailed information about the functional processes within the body, allowing for early detection, precise localization, and effective management of these diseases.

Moreover, a personalized approach improves treatment outcomes and reduces adverse effects. PET scanner technology has witnessed significant advancements in recent years, leading to improved image quality, reduced scanning times, and enhanced diagnostic capabilities. These advances have increased the availability, efficacy, and accuracy of PET scans leading to a further increase in their demand. The demand will thus be driven by the increasing prevalence of chronic diseases.

Significant Market Trends

Technological advancements are a primary market trend.  PET scanner technology has been continuously evolving to provide better image quality, faster scanning times, and improved patient comfort. PET scanners have seen significant improvements in image quality over the years. Advanced reconstruction algorithms and iterative reconstruction techniques have been developed to enhance image resolution, reduce noise, and improve overall image clarity. These improvements have made it possible to diagnose and visualize tiny lesions more accurately.

There has been an increased incidence of TOFPET scanners in recent years. TOF technology measures the time it will take for positrons to be transferred from a patient's body into detectors. For the determination of the precise location of the source of emissions, this information shall be used. In addition, TOF PET enhances the image quality, reduces noise, and enhances scanner sensitivity resulting in quicker scans and a more accurate delineation of abnormalities.

Major Market Challenge

The high cost of PET scanners is a major challenge in the market. PET scanners are expensive to purchase and maintain, making them a significant investment for healthcare facilities. The initial cost of acquiring a PET scanner, along with the ongoing expenses of radiopharmaceuticals and equipment maintenance, can be a barrier for many healthcare providers. The cost burden for users and patients can be higher with the high costs of medical imaging equipment and procedures.

Preventable maintenance, parts, labor charges, and technical assistance costs shall be included in the service maintenance cost. The cost of the end user, for example, hospitals, diagnostics centers, and clinics, is, therefore, further increased. The main reason for this is, therefore, the large costs and related procedures. 

Customer Landscape

The market growth and forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major PET Scanners Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Siemens Healthineers AG. - The company offers PET scanners such as Biograph vision, Biograph vision quadra, and Biograph mCT.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:

  • Blue Earth Diagnostics Ltd.
  • Canon Medical Systems Corp.
  • CellSight Technologies Inc.
  • GE Healthcare Technologies Inc.
  • General de Equipment for Medical Imaging S A
  • Koninklijke Philips NV
  • Mediso Ltd.
  • MinFound Medical Systems Co. Ltd.
  • Modus Medical Devices Inc.
  • Neusoft Corp.
  • Novartis AG
  • Perkin Elmer Inc.
  • PETsys Electronics SA
  • Positron Corp.

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing significant growth due to continuous technical advancements. PET scanners, combined with X-ray Tomography (CT), offer precise 3-dimensional (3D) images crucial for diagnosing various conditions, including coronary artery diseases and brain disorders like Alzheimer's and epilepsy. Radioactive tracers like 18F-fluorodeoxyglucose (FDG) and Gallium 68 PSMA-11 are vital components, enhancing diagnostic accuracy, especially in oncology imaging for prostate cancer detection. Additionally, the integration of Artificial Intelligence (AI) into PET/CT imaging systems further improves diagnostic capabilities, driving demand in oncology and cardiology segments. Despite the high capital and operational costs associated with PET scanners, healthcare investments, research grants, and the presence of specialized personnel contribute to market growth. With expanding applications in precision medicine and the continuous development of advanced imaging technologies, the market is poised for substantial expansion in healthcare settings worldwide.

In the realm of PET scanners, the focus on dementia diagnosis and management is gaining traction. PET scanners, often used in conjunction with CT or MRI, provide invaluable insights into brain function and structure, aiding in the early detection of conditions like dementia. The World Nuclear Association's advocacy for the use of radioisotopes in diagnostic nuclear medicine underscores the importance of scanners in therapeutic applications. Moreover, advancements in PET detector technology, exemplified by innovations like PluvictoTM, enhance diagnostic precision, particularly in oncology and cardiovascular diseases. Companies like Minfound Medical System Co and ScintCare TOF PET/CT are pioneering developments in technology, notably in Hangzhou, China. As hospitals and medical centers continue to invest in state-of-the-art diagnostic imaging centers, PET scanners remain indispensable tools in oncology research and the comprehensive management of complex diseases like dementia.

Segment Overview

The market growth analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user 
    • Hospitals
    • Diagnostic centers
    • Others
  • Application Outlook 
    • Oncology
    • Neurology
    • Cardiology
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa
    • South America
      • Brazil
      • Argentina
      • Chili

 

PET Scanners Market Scope

Report Coverage

Details

Page number

152

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 4.73%

Market growth 2023-2027

USD 477.85 million

Market structure

Fragmented

YoY growth 2022-2023(%)

4.23

Regional analysis

Europe, North America, APAC, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key countries

US, Japan, Germany, France, and UK

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Blue Earth Diagnostics Ltd., Canon Medical Systems Corp., CellSight Technologies Inc., CMR Naviscan Corp., GE Healthcare Technologies Inc., General de Equipment for Medical Imaging S A, Koninklijke Philips NV, Mediso Ltd., MinFound Medical Systems Co. Ltd., Modus Medical Devices Inc., Neusoft Corp., Novartis AG, Perkin Elmer Inc., PETsys Electronics SA, Positron Corp., Radiology Oncology Systems Inc., RefleXion Medical Inc., Shimadzu Corp., Siemens Healthineers AG, and Yangzhou Kindsway Biotech Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across Europe, North America, APAC, and Rest of World (ROW)
  • Through analysis of the market’s competitive landscape and detailed information about Companies
  • Comprehensive analysis of factors that will challenge the growth of market Companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global PET scanners market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global pet scanners market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 6.4 Diagnostic centers - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 48: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 50: Chart on Comparison by Application
      • Exhibit 51: Data Table on Comparison by Application
    • 7.3 Oncology - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Oncology - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
    • 7.4 Neurology - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
    • 7.5 Cardiology - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by Application
      • Exhibit 68: Market opportunity by Application ($ million)
      • Exhibit 69: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.4 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 France - Market size and forecast 2022-2027
      • Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Canon Medical Systems Corp.
              • Exhibit 119: Canon Medical Systems Corp. - Overview
              • Exhibit 120: Canon Medical Systems Corp. - Business segments
              • Exhibit 121: Canon Medical Systems Corp. - Key offerings
              • Exhibit 122: Canon Medical Systems Corp. - Segment focus
            • 12.4 CellSight Technologies Inc.
              • Exhibit 123: CellSight Technologies Inc. - Overview
              • Exhibit 124: CellSight Technologies Inc. - Product / Service
              • Exhibit 125: CellSight Technologies Inc. - Key offerings
            • 12.5 GE Healthcare Technologies Inc.
              • Exhibit 126: GE Healthcare Technologies Inc. - Overview
              • Exhibit 127: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 128: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 129: GE Healthcare Technologies Inc. - Segment focus
            • 12.6 Koninklijke Philips NV
              • Exhibit 130: Koninklijke Philips NV - Overview
              • Exhibit 131: Koninklijke Philips NV - Business segments
              • Exhibit 132: Koninklijke Philips NV - Key news
              • Exhibit 133: Koninklijke Philips NV - Key offerings
              • Exhibit 134: Koninklijke Philips NV - Segment focus
            • 12.7 Mediso Ltd.
              • Exhibit 135: Mediso Ltd. - Overview
              • Exhibit 136: Mediso Ltd. - Product / Service
              • Exhibit 137: Mediso Ltd. - Key offerings
            • 12.8 MinFound Medical Systems Co. Ltd.
              • Exhibit 138: MinFound Medical Systems Co. Ltd. - Overview
              • Exhibit 139: MinFound Medical Systems Co. Ltd. - Product / Service
              • Exhibit 140: MinFound Medical Systems Co. Ltd. - Key offerings
            • 12.9 Modus Medical Devices Inc.
              • Exhibit 141: Modus Medical Devices Inc. - Overview
              • Exhibit 142: Modus Medical Devices Inc. - Product / Service
              • Exhibit 143: Modus Medical Devices Inc. - Key offerings
            • 12.10 Neusoft Corp.
              • Exhibit 144: Neusoft Corp. - Overview
              • Exhibit 145: Neusoft Corp. - Product / Service
              • Exhibit 146: Neusoft Corp. - Key offerings
            • 12.11 Perkin Elmer Inc.
              • Exhibit 147: Perkin Elmer Inc. - Overview
              • Exhibit 148: Perkin Elmer Inc. - Business segments
              • Exhibit 149: Perkin Elmer Inc. - Key news
              • Exhibit 150: Perkin Elmer Inc. - Key offerings
              • Exhibit 151: Perkin Elmer Inc. - Segment focus
            • 12.12 PETsys Electronics SA
              • Exhibit 152: PETsys Electronics SA - Overview
              • Exhibit 153: PETsys Electronics SA - Product / Service
              • Exhibit 154: PETsys Electronics SA - Key offerings
            • 12.13 Positron Corp.
              • Exhibit 155: Positron Corp. - Overview
              • Exhibit 156: Positron Corp. - Product / Service
              • Exhibit 157: Positron Corp. - Key offerings
            • 12.14 RefleXion Medical Inc.
              • Exhibit 158: RefleXion Medical Inc. - Overview
              • Exhibit 159: RefleXion Medical Inc. - Product / Service
              • Exhibit 160: RefleXion Medical Inc. - Key offerings
            • 12.15 Shimadzu Corp.
              • Exhibit 161: Shimadzu Corp. - Overview
              • Exhibit 162: Shimadzu Corp. - Business segments
              • Exhibit 163: Shimadzu Corp. - Key news
              • Exhibit 164: Shimadzu Corp. - Key offerings
              • Exhibit 165: Shimadzu Corp. - Segment focus
            • 12.16 Siemens Healthineers AG
              • Exhibit 166: Siemens Healthineers AG - Overview
              • Exhibit 167: Siemens Healthineers AG - Business segments
              • Exhibit 168: Siemens Healthineers AG - Key news
              • Exhibit 169: Siemens Healthineers AG - Key offerings
              • Exhibit 170: Siemens Healthineers AG - Segment focus
            • 12.17 Yangzhou Kindsway Biotech Co. Ltd.
              • Exhibit 171: Yangzhou Kindsway Biotech Co. Ltd. - Overview
              • Exhibit 172: Yangzhou Kindsway Biotech Co. Ltd. - Product / Service
              • Exhibit 173: Yangzhou Kindsway Biotech Co. Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 174: Inclusions checklist
                • Exhibit 175: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 176: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 177: Research methodology
                • Exhibit 178: Validation techniques employed for market sizing
                • Exhibit 179: Information sources
              • 13.5 List of abbreviations
                • Exhibit 180: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              pet scanners market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis